Literature DB >> 21940695

Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?

Hilde Nordgarden1, Ingvild Østerhus, Anne Møystad, Pamela Asten, Ulf L-H Johnsen, Kari Storhaug, Jens Øyvind Loven.   

Abstract

There are several treatment options available for drooling; botulinum toxin injections into the major salivary glands are one. There is no consensus as to how many and which glands should be injected. A research project on this topic was terminated because of adverse effects. Individual results and the adverse effects are described and discussed in this article. Six individuals with cerebral palsy were randomly allocated to 2 treatment groups, with five individuals receiving ultrasound-guided injections to parotid and submandibular glands and one receiving injections to the submandibular glands only. Reduction of observed drooling was registered in 3, while 4 patients reported subjective improvement (Visual Analog Scale). Two participants reported adverse effects, including dysphagia, dysarthria, and increased salivary viscosity. Injections with botulinum toxin can be a useful treatment option but there is a risk of adverse effects. Multidisciplinary evaluation and informed discussions with patients/caregivers are important factors in the decision-making process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940695     DOI: 10.1177/0883073811419365

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.

Authors:  Eigild Møller; Søren Anker Pedersen; Pablo Gustavo Vinicoff; Allan Bardow; Joan Lykkeaa; Pia Svendsen; Merete Bakke
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

Review 2.  A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome.

Authors:  Jessica Duis; Mark Nespeca; Jane Summers; Lynne Bird; Karen G C B Bindels-de Heus; M J Valstar; Marie-Claire Y de Wit; C Navis; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Susan Ernst; Melina Dendrinos; Terry Katz; Gloria Diaz-Medina; Akshat Katyayan; Srishti Nangia; Ronald Thibert; Daniel Glaze; Christopher Keary; Karine Pelc; Nicole Simon; Anjali Sadhwani; Helen Heussler; Anne Wheeler; Caroline Woeber; Margaret DeRamus; Amy Thomas; Emily Kertcher; Lauren DeValk; Kristen Kalemeris; Kara Arps; Carol Baym; Nicole Harris; John P Gorham; Brenda L Bohnsack; Reid C Chambers; Sarah Harris; Henry G Chambers; Katherine Okoniewski; Elizabeth R Jalazo; Allyson Berent; Carlos A Bacino; Charles Williams; Anne Anderson
Journal:  Mol Genet Genomic Med       Date:  2022-02-11       Impact factor: 2.183

3.  Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study.

Authors:  Johanna Norderyd; Jonas Graf; Agneta Marcusson; Karolina Nilsson; Eva Sjöstrand; Gunilla Steinwall; Elinor Ärleskog; Mats Bågesund
Journal:  Int J Paediatr Dent       Date:  2015-12-27       Impact factor: 3.455

4.  Botulinum Toxin Injections for Treatment of Drooling in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis.

Authors:  Shang-An Hung; Chung-Lun Liao; Wei-Pin Lin; Jason C Hsu; Yao-Hong Guo; Yu-Ching Lin
Journal:  Children (Basel)       Date:  2021-11-25

5.  Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI.

Authors:  Steffen Berweck; Marcin Bonikowski; Heakyung Kim; Michael Althaus; Birgit Flatau-Baqué; Daniela Mueller; Marta Dagmara Banach
Journal:  Neurology       Date:  2021-08-02       Impact factor: 11.800

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.